1. Ahrens I, Bode C. Rivaroxaban for stroke prevention in atrial fibrillation and secondary prevention in patients with a recent acute coronary syndrome. Future Cardiol. 2012 Jul;8(4):533-41.
2. Carter KL, Streiff MB, Ross PA, Wellman JC, Thomas ML, Kraus PS, Shermock KM. Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The Johns Hopkins Hospital. J Thromb Thrombolysis. 2012 Aug 4.
|